FBC
MRNA icon

Fairfield, Bush & Co’s Moderna MRNA Stock Holding History

Fairfield, Bush & Co’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-6,800
Closed -$826K – 356
2023
Q2 		$826K Hold
6,800
– – 0.23% 81
2023
Q1 		$1.04M Buy
+6,800
New +$1.12M 0.37% 65
2021
Q4 		– Sell
-4,800
Closed -$1.85M – 153
2021
Q3 		$1.85M Buy
+4,800
New +$1.77M 0.6% 45
2021
Q2 		– Sell
-4,000
Closed -$524K – 158
2021
Q1 		$524K Hold
4,000
– – 0.15% 116
2020
Q4 		$418K Buy
+4,000
New +$405K 0.12% 116
2020
Q3 		– Sell
-4,000
Closed -$257K – 149
2020
Q2 		$257K Buy
+4,000
New +$219K 0.09% 121

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Fairfield, Bush & Co's MRNA Position: Q3 2023 in Review

Fairfield, Bush & Co sold out of Moderna (MRNA) in Q3 2023, closing a stake of 6,800 shares — an estimated $826K sold.

Fairfield, Bush & Co first reported a position in MRNA in Q2 2020 and held it in 6 quarters. The position peaked at $1.85M in Q3 2021. 890 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • Fairfield, Bush & Co reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • Fairfield, Bush & Co sold 6,800 Moderna shares in Q3 2023, an estimated $826K.
  • Fairfield, Bush & Co first reported a position in Moderna in Q2 2020 and held it in 6 quarters.
  • Fairfield, Bush & Co's Moderna position peaked at $1.85M in Q3 2021.
  • 890 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Fairfield, Bush & Co's 13F filing for Q3 2023, filed 15 Nov 2023.